Why the study?
Central obesity is increasing rapidly and closely linked to chronic diseases, metabolic complications, and high COVID-19 infection rates, but its dominant risk factors required identification.
Hypercholesterolemia is strongly associated with central obesity in this Indonesian adult cohort, highlighting the link between lipid metabolism and abdominal adiposity.
Hypercholesterolemia may flag central-obesity risk in similar clinics; leaves open causality and should not yet change practice.
The prevalence of central obesity has been increasing rapidly in recent decades. Central obesity, measured by waist circumference, is the most dangerous type of obesity since it is closely related to chronic diseases, metabolic complications, and high COVID-19 infection rates. The objective of this study was to identify the dominant factor of central obesity among the adult population. The study used secondary data from a 2017 cross-sectional study conducted at Bojong Gede Public Health Center, Bogor Regency, Indonesia. A total of 85 men and women aged 25–64 years old were selected through purposive sampling and included in the analysis. The association between risk factors and central obesity were measured through chi-square bivariate analysis and multiple logistic regression multivariate analysis using IBM SPSS application version 22. The prevalence of central obesity was 70.6%. The results showed that sex (women), total blood cholesterol level (hypercholesterolemia), energy, protein, fat, and carbohydrate intake (>110%personal nutritional needs) were significantly associated with central obesity ( p-value < 0.05). Hypercholesterolemia was the most dominant risk factor for central obesity ( p-value = 0.032; OR = 4.21; 95%CI = 1.131–15.667) adjusted for confounders.
No takes yet. Share an insight, caveat, or question.
Latif et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: